Glycologix ^Company

Glycologix LLC is an emerging biotechnology company targeting locally delivered therapeutics for the protection and repair of soft tissues. Multiple unmet medical conditions can be addressed by replenishment of naturally occurring proteoglycans. Its platform discovery engine enables the preparation of synthetic structural mimics of proteoglycans. These novel materials are branched, sulfated, high molecular weight and highly soluble to enable optimal tissue coverage. This proprietary chemistry enables the optimization of polymers towards target tissues to rapidly address many therapeutics areas. Focused indications include interstitial cystitis, osteoarthritis, spinal disk disease, adhesion prevention, and wound repair. Glycologix is supported by grants from the National Institutes of Health as well as individual investors and is currently raising a seed round to support our first clinical trial.